Aspergyllosis was investigated with our own cases and contributed records from other 44 universities and hospitals with a special consideration to the relation with steroid therapy.
The incidence in our hospital is as follows: Among 3596 cases admitted to the department of internal medicine, Kawasaki City Hospital, during a four-year-period from Jan., 1962 to the end of Dec., 1965, 365 cases were treated more or less with steroid hormone, of which 12 (3.3%) were considered to be socalled steroid induced infection, out of which 6 were Aspergyllosis.
The number of Mycosis cases associated with steroid therapy including both our cases and contributed ones was 73, of which 32 were Aspergyllosis, 31, Candidiasis, 8, Cryptococcosis and 2, Mucor Mycosis.
The number of Aspergyllosis cases including cases without steroid therapy was 66. Thus, the cases of Aspergyllosis with steroid therapy, 32 in all, occupies 48.4% of all Aspergyllosis cases recognized.
There were two types in these secondary Asper gyllosis, localized and disseminated type. Of those 32 Aspergyllosis cases, 17 were of localized type and 15, of disseminated type. There have been no cases of disseminated type in the cases without steroid therapy. This fact suggests the influence of steroid to the developmental mode of Asper gyllus infection.
Frequently encountered underlying diseases in those 32 Aspergyllosis cases were blood disease, especially leucaemia, respiratory disease, and liver disease in order. It is noteworthy that in the cases without steroid administration, only respiratory disease was found to be underlying ailment, and the Aspergyllosis was of localized type in all.
Antibiotics administration was most common to accompany with steroid therapy. In some cases, anti-cancer agents were added. In the cases to which such three kinds of medicine were given, disseminated type predominated. And further tendency is that disseminated type was apparently increased in the choice of broad spectrum antibiotics rather than narrow-spectrum ones.
Although it should be admittable that the definite factor causing and developing secondary Aspergyllosis was diminishing resistance of the hosts, it is undeniable from the data in this survey that steroid hormone itself or, accompanied by antibiotics or cytotoxic agents, also played the significant role to it. It is quite impossible at this stage to clarify precise mechanisms of steroid action to the infection like mycosis, but, it would not be so inconsistent to regard most of the cases here as steroid induced infection. Especially, the role of steroid to the development of disseminated type Aspergyllosis should never be underestimated.
Some clinical data are also presented: The clinical diagnosis was extremely difficult. Here, only 3 out of 32 could be ascertained before autopsy. Consequently, clinical applications of anti-fungal agents were very rare. Although the symptoms of underlying illness were apt to overshadow the clinical manifestations of Aspergyllosis, fever, respiratory disorders, anemia and hypoproteinemia were most commonly encountered symptoms of it in order. The data about prognosis were also discouraging. The death rate as a whole was 81.2%. There were no survival cases of disseminated type. The autopsy revealed lung was the most frequently involved organ.
View full abstract